Relative Intelligence · Medical Devices

How Medtronic (MDT) compares with the whole market and its popular alternatives
Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on MDT alone. It places MDT (Medtronic Plc) against 20+ popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where MDT stands in the market, and of the alternatives worth a closer look.
Period covered: MDT's full trading record, from October 1986 through September 2026. All returns include reinvested dividends. Data as of October 20, 2026.
Data as of October 20, 2026. Full tables and charts read best on a larger screen.
On this page12 sections
Key findings
- Right nowOver the past 3 months, MDT rose 14.5% against 3.9% for the S&P 500 and 3.2% for the Nasdaq 100. Not every peer went the same way. Over the past 3 months, ITGR (Integer) rose 31.9% and SYK (Stryker) fell 4.3%. Consistency ↓
- Stock or market?MDT's 14.5% gain over the past 3 months far outran its industry: the medical devices ETF IHI (iShares U.S. Medical Devices ETF) rose 7.5%. The S&P 500 rose 3.9%. Its medical device peers did not move as one over the past 3 months: ITGR (Integer) rose 31.9%, while SYK (Stryker) fell 4.3%.
- Past 1 to 3 yearsMDT has trailed the market, rising 1.9% over the past year against 15.8% for the S&P 500 and 17.9% for the Nasdaq 100. The same gap shows up over 3 years (43.6% against 89.3%). By year ↓
- Long termMDT turned $10,000 into $14,700 over the past decade, against $42,100 in the S&P 500. Growth of $10,000 ↓
- In a crashThe late-2018 sell-off took 13.8% off MDT, against 19.3% for the S&P 500. That was more than ABT (Abbott Laboratories, 11.7%) but less than JNJ (Johnson & Johnson, 16.9%). That said, MDT fell further than the S&P 500 in three of the last four sell-offs, including the 2015 China and oil sell-off (17.6% against 12.8%). Crash tests ↓
- DiversificationOver 10 years MDT took more of the market's losses than of its gains: in the S&P 500's rising months it gained 62% as much as the index, and in falling months it lost 1.0 times as much, with a beta of 0.68. When the S&P 500 had a down month, MDT usually fell with it (18 of 22 months). By year ↓
- Better options
- Nearby categories and themes
- TAK (Takeda Pharmaceutical, pharmaceuticals) and NVS (Novartis, pharmaceuticals) earned more than MDT with less volatility over the past 5 years. TAK returned 11.9% a year at 19.4% volatility, against a loss of 1.8% a year at 22.5%.
- Whole market
- 869 of the 3,633 stocks and funds worth at least $500 million earned more than MDT with less volatility over the past 5 years, among them VTI (Vanguard Morningstar Total Stock Market ETF), VOO (Vanguard S&P 500 ETF) and BRK-B (Berkshire Hathaway).
How much would $10,000 in MDT have grown?
This chart tracks a hypothetical $10,000 investment in MDT over the past 29 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of MDT over the same span and MDT's popular alternatives, among those that traded for the entire period. A second view covers the past 5 years, the period the better options further down the page are judged on. It shows not only where each investment ended up but also how smooth or uneven the path was.
- $10,000 invested in MDT at the end of September 1997 would have grown to $61,200 by September 2026, less than the $132,907 it would have become in SPY, an S&P 500 fund.
- Seven of the eight other investments on the chart ended ahead of MDT, and UNH finished highest, at $772,802.
Choose a period
From the end of September 1997 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 692 of the 1,042 stocks and funds worth at least $500 million that traded the whole period ended ahead of MDT; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- UNH$772,802+7,628% total · +16.2% a year
- SYK$323,233+3,132% total · +12.7% a year
- MCK$208,304+1,983% total · +11.0% a year
- JNJ$189,226+1,792% total · +10.7% a year
- STE$142,090+1,321% total · +9.6% a year
- SPY (S&P 500)$132,907+1,229% total · +9.3% a year
- ABT$130,278+1,203% total · +9.3% a year
- CAH$113,257+1,033% total · +8.7% a year
- MDT$61,200+512% total · +6.4% a year
- BSX$31,631+216% total · +4.1% a year
From the end of September 2021 to the end of September 2026. Hover over a fund in the key to pick out its line. 2,900 of the 3,628 stocks and funds worth at least $500 million that traded the whole period ended ahead of MDT; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- CAH$49,682+397% total · +37.8% a year
- MCK$43,941+339% total · +34.5% a year
- SPY (S&P 500)$19,000+90.0% total · +13.7% a year
- JNJ$18,849+88.5% total · +13.5% a year
- HCA$18,335+83.3% total · +12.9% a year
- ITGR$14,142+41.4% total · +7.2% a year
- BDX$10,410+4.1% total · +0.8% a year
- UNH$10,283+2.8% total · +0.6% a year
- LIVN$9,660−3.4% total · −0.7% a year
- MDT$8,078−19.2% total · −4.2% a year
MDT at a glance
This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.
- MDT's deepest decline since it began trading in 1986 was 57.6%, from January 2006 to March 2009. It took about four years from the low to climb back to its old high.
- Over 29 full calendar years, MDT's best was 2000, when it returned 66.4%, and its worst was 2008, when it lost 36.3%. It lost money in ten of those years.
- MDT is 17.4% below its all-time high.
The company
- Market value
- $121B
- Industry
- Medical - Devices
- Price history from
- October 1986
Returns
- Past 1 year
- +1.9%total return
- Past 3 years
- +43.6%+12.8% a year
- Past 5 years
- −8.8%−1.8% a year
- Past 10 years
- +46.7%+3.9% a year
- Best calendar year
- +66.4%2000
- Worst calendar year
- −36.3%2008
- Losing years
- 10 of 29full calendar years
Risk
- Volatility
- 22.5%typical yearly swing, 5 years
- Sharpe ratio
- 0.03return per unit of risk, 5 years
- Worst decline ever
- −57.6%Jan 2006 to Mar 2009
- From its all-time high
- −17.4%below the peak
MDT against the whole market
Where MDT ranks among every stock and fund, and what across the market has done better.
How does MDT rank among all stocks?
This section ranks MDT on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how MDT stacks up against its peers, these rankings show where it stands in the market as a whole.
- MDT is among the steadier stocks: its price swings rank in the top 6% of the 2,893 stocks worth at least $300 million, where the top is the calmest.
- On return for the risk taken (the Sharpe ratio), MDT ranks in the bottom 21% of the 2,893 stocks worth at least $300 million.
Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.
| Measure | MDT | Rank | Standing |
|---|---|---|---|
| 1-year return | +1.9% | 1,915 of 3,287 | bottom 43% |
| 3-year return | +43.6% | 1,648 of 3,017 | bottom 46% |
| 5-year return | −8.8% | 1,848 of 2,893 | bottom 37% |
| 10-year return | +46.7% | 1,592 of 2,202 | bottom 29% |
| Volatility, 5 years | 22.5% | 172 of 2,893 | top 6% |
| Sharpe ratio, 5 years | 0.03 | 2,276 of 2,893 | bottom 22% |
| Worst decline, past 10 years | −45.1% | 294 of 2,187 | top 13% |
What has beaten MDT on both return and risk?
Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer). MDT sits where the dashed lines cross. Anything in the green box above and to the left earned more than MDT with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.
- 95 stocks and 774 ETFs worth at least $500 million sit in the green region: each earned more than MDT over the past 5 years with smaller price swings. That is 24% of the 3,633 screened.
- Among those with at least half MDT's swings, DXJ has the best return for its risk: 26.6% a year at 19.1% volatility, 15% less than MDT's 22.5%, and a Sharpe ratio (return above cash per unit of volatility) of 1.34 against 0.03 for MDT.
- Among MDT's popular alternatives, JNJ is in the region. JNJ earned 12.7% a year against a loss of 1.8% a year for MDT, at 17.9% volatility, 20% less than MDT's 22.5%.
Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 5 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to MDT; faint dots are 92 more of the 869 in the green region (the strongest, one per fund family). 3,633 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.
- Popular alternatives
- Same and neighboring categories, and shared themes
- The whole market
- Others in the green region
Is there a better investment than MDT?
Investments that beat MDT over the past 5 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.
- Among MDT's popular alternatives, JNJ earned more than MDT with less volatility over the past 5 years: 12.7% a year at 17.9% volatility, against a loss of 1.8% a year at 22.5%.
- Looking beyond its popular alternatives, TAK (pharmaceuticals) and NVS (pharmaceuticals) earned more than MDT with less volatility over the past 5 years. TAK returned 11.9% a year at 19.4% volatility, against a loss of 1.8% a year at 22.5%.
- Across the whole market, 869 of the 3,633 stocks and funds worth at least $500 million earned more than MDT with less volatility over the past 5 years, among them VTI, VOO and BRK-B.
How this works
The table below lists investments that beat MDT over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks MDT's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than MDT follows the table.
Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 5 years; the worst decline covers the past 10 years. Green marks a better figure than MDT's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× MDT's volatility counts as better.
These figures cover the past 5 years. Green marks a better figure than MDT's.
| Investment | Why it is better | Past 5 years | Downside | Long run | Fit | ||||
|---|---|---|---|---|---|---|---|---|---|
| Annual return?higher is better | Volatility?lower is calmer | Sharpe?return per unit of risk | Worst decline?past 10 years | 10Y returntotal | Corr. with MDT?lower diversifies more | Expenseper year | |||
| −1.8% | 22.5% | 0.03 | −45.1% | +46.7% | 1.00 | — | |||
| +12.7% | 17.1% | 0.79 | −33.7% | +321% | 0.36 | 0.09% | |||
| Popular alternativesbest 6 shownThe investments people most often weigh against MDT. 9 of 23 passed at least one test. | |||||||||
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +2.3% | 24.1% | 0.22 | −39.9% | +71.4% | 0.45 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.53 | — | ||
| Higher Sharpe, smaller worst declineHigher return in most periods | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.21 | — | ||
| On the frontierHigher return in most periods | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.41 | — | ||
| Higher return in most periods | +14.1% | 30.1% | 0.59 | −54.7% | +513% | 0.58 | — | ||
| Higher return in most periods | +1.1% | 32.1% | 0.20 | −61.4% | +241% | 0.07 | — | ||
| Same and neighboring categories, and shared themesbest 6 shownEverything else in Medical Devices and the categories next to it (Health Care Facilities, Pharmaceuticals, Life Sciences Tools, Health Care Distribution), plus MDT's specific themes. 18 of 53 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher return in most periods | +11.9% | 19.4% | 0.68 | −54.4% | +30.4% | 0.33 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +17.1% | 20.7% | 0.87 | −26.8% | +226% | 0.42 | — | ||
| Higher Sharpe, smaller worst declineHigher return in most periods | +40.7% | 32.8% | 1.21 | −34.5% | +1,807% | 0.19 | — | ||
| Higher return, similar volatilityHigher return in most periods | +26.1% | 23.4% | 1.11 | −45.1% | +603% | 0.27 | — | ||
RPRXRoyalty Pharma plc · Pharmaceuticals | Higher return, similar volatilityHigher return in most periods | +13.3% | 23.8% | 0.65 | −49.7% | — | 0.23 | — | |
| Higher return, similar volatilityHigher Sharpe, smaller worst decline | +24.2% | 22.8% | 1.07 | −32.4% | +406% | 0.56 | — | ||
| The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 1,338 of 3,557 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +13.4% | 17.1% | 0.82 | −29.6% | +274% | 0.50 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.35 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +11.4% | 14.7% | 0.81 | −38.5% | +205% | 0.54 | 0.18% | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +11.2% | 20.8% | 0.62 | −37.4% | +319% | 0.17 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +7.2% | 19.2% | 0.46 | −29.0% | +68.8% | 0.22 | — | ||
FLRTPacer Aristotle Pacific Floating Rate High Income ETF · Financials | On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes | +6.0% | 2.3% | 2.55 | −21.0% | +58.0% | 0.30 | 0.60% | |
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +12.8% | 22.9% | 0.64 | −36.4% | +429% | 0.40 | — | ||
| Similar return, lower volatility | −1.7% | 11.3% | -0.10 | −19.4% | — | 0.23 | — | ||
What these numbers mean for MDT
- Annual return
- MDT lost 1.8% a year over the past 5 years with dividends reinvested, against 12.7% a year for the S&P 500. At that pace, $10,000 became about $9,120. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
- Volatility
- MDT's volatility over the past 5 years was 22.5%, 1.3 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, MDT's return lands within 22.5% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
- Sharpe ratio
- MDT's Sharpe ratio over the past 5 years was 0.03, against 0.79 for the S&P 500, so MDT earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
- Worst decline
- MDT's worst fall from a peak to a low over the past 10 years was 45.1%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 45.1% fall takes a 82.1% gain. Guide: Market crash risk and tail risk →
- Correlation
- Over the past 5 years, MDT's monthly returns had a correlation of 0.36 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against MDT instead: the lower it is, the more that option would diversify a MDT holding. Guide: Correlation and diversification →
Show all 869 stocks and funds worth at least $500 million that earned more than MDT with less volatility
Out of 3,633 tested over 5 years. The strongest 100 are listed, best first, with funds that hold the same thing listed once.
| # | Investment | Found in | Annual return | Volatility | Sharpe | Worst decline | 10Y return | Corr. with MDT | Expense |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Whole market | +13.4% | 17.1% | 0.82 | −29.6% | +274% | 0.50 | — | |
| 2 | Whole market | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.35 | — | |
| 3 | Whole market | +11.4% | 14.7% | 0.81 | −38.5% | +205% | 0.54 | 0.18% | |
| 4 | Whole market | +11.2% | 20.8% | 0.62 | −37.4% | +319% | 0.17 | — | |
| 5 | Whole market | +7.2% | 19.2% | 0.46 | −29.0% | +68.8% | 0.22 | — | |
| 6 | Whole market | +8.4% | 15.3% | 0.60 | −28.4% | +202% | 0.58 | 0.08% | |
| 7 | HDViShares Core High Dividend ETF · US Dividend Equity | Whole market | +12.9% | 13.0% | 1.00 | −37.0% | +172% | 0.56 | 0.08% |
| 8 | JQUAJPMorgan U.S. Quality Factor ETF · US Quality Equity | Whole market | +13.6% | 15.7% | 0.89 | −32.9% | — | 0.38 | 0.12% |
| 9 | FLRTPacer Aristotle Pacific Floating Rate High Income ETF · Financials | Whole market | +6.0% | 2.3% | 2.55 | −21.0% | +58.0% | 0.30 | 0.60% |
| 10 | Whole market | +17.7% | 18.9% | 0.96 | −26.4% | +213% | 0.23 | 0.40% | |
| 11 | Whole market | +5.1% | 18.3% | 0.37 | −23.8% | +145% | 0.18 | — | |
| 12 | Whole market | +11.5% | 20.9% | 0.63 | −32.6% | +394% | 0.26 | — | |
| 13 | Whole market | +3.8% | 0.3% | 13.25 | −0.3% | — | 0.17 | 0.09% | |
| 14 | IWXiShares Russell Top 200 Value ETF · Broad Market | Whole market | +12.7% | 13.8% | 0.94 | −35.8% | +221% | 0.54 | 0.20% |
| 15 | Whole market | +13.9% | 18.5% | 0.80 | −34.0% | +446% | 0.32 | — | |
| 16 | DIVBiShares Core Dividend ETF · Dividend & Income | Whole market | +13.9% | 15.4% | 0.93 | −36.9% | — | 0.48 | 0.05% |
| 17 | Whole market | +17.3% | 18.2% | 0.97 | −40.0% | +352% | 0.40 | — | |
| 18 | FVFirst Trust Dorsey Wright Focus 5 ETF · Broad Market | Whole market | +9.7% | 21.1% | 0.55 | −34.0% | +247% | 0.38 | 0.30% |
| 19 | Whole market | +9.3% | 19.2% | 0.56 | −30.1% | +344% | 0.30 | — | |
| 20 | FHLCFidelity MSCI Health Care Index ETF · Healthcare | Whole market | +7.3% | 15.4% | 0.53 | −28.8% | +199% | 0.60 | 0.08% |
| 21 | Whole market | +12.4% | 20.2% | 0.68 | −32.9% | +185% | 0.29 | — | |
| 22 | DSTLDistillate U.S. Fundamental Stability & Value ETF · Broad Market | Whole market | +11.3% | 16.1% | 0.75 | −33.1% | — | 0.51 | 0.39% |
| 23 | JAAAJanus Henderson AAA CLO ETF · CLO Bonds | Whole market | +5.1% | 1.7% | 2.98 | −2.6% | — | 0.21 | 0.20% |
| 24 | Whole market | +12.0% | 18.8% | 0.70 | −30.9% | +114% | 0.26 | — | |
| 25 | COMTiShares GSCI Commodity Dynamic Roll Strategy ETF · Commodities | Whole market | +13.1% | 21.1% | 0.69 | −39.2% | +160% | 0.14 | 0.49% |
| 26 | ATOAtmos Energy Corporation · Gas Utilities | Whole market | +14.9% | 18.4% | 0.85 | −32.9% | +194% | 0.27 | — |
| 27 | CHTChunghwa Telecom Co., Ltd. · Integrated Telecommunications | Whole market | +7.7% | 13.3% | 0.63 | −23.8% | +101% | 0.19 | — |
| 28 | FTXHFirst Trust Nasdaq Pharmaceuticals ETF · Healthcare | Whole market | +11.9% | 16.9% | 0.75 | −32.1% | +153% | 0.53 | 0.60% |
| 29 | QQEWFirst Trust Nasdaq-100 Select Equal Weight ETF · Technology | Whole market | +6.8% | 21.3% | 0.42 | −32.1% | +267% | 0.28 | 0.55% |
| 30 | Whole market | +6.5% | 20.9% | 0.41 | −34.4% | +156% | 0.27 | — | |
| 31 | IDHQInvesco S&P International Developed Quality ETF · International | Whole market | +10.0% | 17.9% | 0.63 | −33.6% | +183% | 0.37 | 0.29% |
| 32 | HYGHiShares Interest Rate Hedged High Yield Bond ETF · Bonds | Whole market | +6.6% | 7.1% | 0.94 | −23.9% | +74.5% | 0.41 | 1.12% |
| 33 | Whole market | +6.1% | 20.0% | 0.40 | −31.6% | +270% | 0.34 | — | |
| 34 | NINiSource Inc · Gas Utilities | Whole market | +15.1% | 20.3% | 0.80 | −30.9% | +158% | 0.30 | — |
| 35 | WECWEC Energy Group, Inc. · Electric Utilities | Whole market | +7.2% | 19.0% | 0.46 | −32.3% | +159% | 0.32 | — |
| 36 | USMViShares MSCI USA Min Vol Factor ETF · US Low-Volatility Equity | Whole market | +7.6% | 12.3% | 0.66 | −33.1% | +176% | 0.49 | 0.15% |
| 37 | AEEAmeren Corporation · Electric Utilities | Whole market | +7.9% | 19.4% | 0.49 | −29.1% | +192% | 0.32 | — |
| 38 | Whole market | +11.5% | 17.5% | 0.71 | −35.0% | +302% | 0.38 | 0.03% | |
| 39 | RSPHInvesco S&P 500 Equal Weight Health Care ETF · Healthcare | Whole market | +6.1% | 16.8% | 0.44 | −30.4% | +177% | 0.62 | 0.40% |
| 40 | Whole market | +12.8% | 16.9% | 0.80 | −34.0% | +324% | 0.36 | 0.03% | |
| 41 | BKLNInvesco Senior Loan ETF · Bank Loans | Whole market | +5.4% | 4.5% | 1.19 | −24.1% | +50.7% | 0.39 | 0.67% |
| 42 | CMSCMS Energy Corporation · Electric Utilities | Whole market | +5.6% | 19.0% | 0.38 | −29.6% | +123% | 0.30 | — |
| 43 | SRLNState Street Blackstone Senior Loan ETF · Bank Loans | Whole market | +4.7% | 3.9% | 1.18 | −22.3% | +54.2% | 0.36 | 0.70% |
| 44 | LNTAlliant Energy Corporation · Electric Utilities | Whole market | +7.3% | 19.8% | 0.46 | −33.5% | +150% | 0.30 | — |
| 45 | HYGiShares iBoxx $ High Yield Corporate Bond ETF · High Yield Bonds | Whole market | +3.1% | 7.5% | 0.45 | −22.0% | +49.5% | 0.44 | 0.49% |
| 46 | Whole market | +15.8% | 20.0% | 0.84 | −42.0% | +310% | 0.28 | — | |
| 47 | FTSLFirst Trust Senior Loan Fund · Bonds | Whole market | +5.0% | 3.4% | 1.49 | −22.7% | +52.1% | 0.30 | 0.70% |
| 48 | Whole market | +17.8% | 21.4% | 0.88 | −53.7% | +140% | 0.40 | — | |
| 49 | IDAIDACORP, Inc. · Electric Utilities | Whole market | +8.8% | 19.2% | 0.54 | −34.3% | +141% | 0.25 | — |
| 50 | EFAViShares MSCI EAFE Min Vol Factor ETF · International Equity | Whole market | +7.6% | 11.9% | 0.68 | −27.6% | +97.7% | 0.44 | 0.20% |
| 51 | DXJWisdomTree Japan Hedged Equity Fund · International Equity | Whole market | +26.6% | 19.1% | 1.34 | −39.1% | +428% | 0.24 | 0.48% |
| 52 | LVHIFranklin International Low Volatility High Dividend Index ETF · International Equity | Whole market | +17.0% | 11.1% | 1.48 | −32.4% | +194% | 0.48 | 0.40% |
| 53 | Whole market | +12.9% | 19.9% | 0.71 | −46.9% | +187% | 0.38 | — | |
| 54 | PTLCPacer Trendpilot US Large Cap ETF · Broad Market | Whole market | +9.5% | 11.8% | 0.83 | −26.6% | +188% | 0.31 | 0.60% |
| 55 | BALTInnovator Defined Wealth Shield ETF · Crypto | Whole market | +6.3% | 3.3% | 1.85 | −4.9% | — | 0.38 | 0.69% |
| 56 | Whole market | +8.2% | 16.4% | 0.57 | −36.0% | +140% | 0.37 | 0.05% | |
| 57 | SRSpire Inc. · Gas Utilities | Whole market | +9.7% | 21.2% | 0.55 | −39.5% | +98.3% | 0.31 | — |
| 58 | AORiShares Core 60/40 Balanced Allocation ETF · Multi-Asset | Whole market | +6.4% | 10.7% | 0.64 | −23.0% | +118% | 0.40 | 0.20% |
| 59 | VRIGInvesco Variable Rate Investment Grade ETF · Bonds | Whole market | +4.7% | 1.3% | 3.51 | −13.1% | +40.5% | 0.27 | 0.30% |
| 60 | FPEFirst Trust Preferred Securities and Income ETF · Preferred Securities | Whole market | +2.0% | 6.7% | 0.34 | −33.3% | +51.3% | 0.41 | 0.83% |
| 61 | ACWViShares MSCI Global Min Vol Factor ETF · International | Whole market | +6.3% | 10.3% | 0.65 | −28.8% | +116% | 0.52 | 0.20% |
| 62 | CWBState Street SPDR Bloomberg Convertible Securities ETF · Corporate Bonds | Whole market | +3.7% | 13.7% | 0.34 | −32.1% | +178% | 0.28 | 0.40% |
| 63 | NFRANorthern Trust STOXX Global Broad Infrastructure ETF · International | Whole market | +5.3% | 12.9% | 0.46 | −32.5% | +95.1% | 0.45 | 0.48% |
| 64 | Whole market | +9.3% | 16.9% | 0.61 | −35.8% | +153% | 0.41 | 0.03% | |
| 65 | HYSPIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund · Bonds | Whole market | +4.5% | 6.3% | 0.74 | −20.9% | +57.5% | 0.45 | 0.56% |
| 66 | SDCIUSCF SummerHaven Dynamic Commodity Strategy No K-1 Fund · Bonds | Whole market | +20.6% | 18.4% | 1.12 | −45.7% | — | 0.22 | 0.80% |
| 67 | Whole market | +11.7% | 19.4% | 0.67 | −50.8% | +255% | 0.28 | — | |
| 68 | DBAInvesco DB Agriculture Fund · Alternatives | Whole market | +10.7% | 13.8% | 0.81 | −35.3% | +62.2% | 0.25 | 0.90% |
| 69 | ANGLVanEck Fallen Angel High Yield Bond ETF · Multi-Asset | Whole market | +1.9% | 7.7% | 0.28 | −29.3% | +60.5% | 0.44 | 0.25% |
| 70 | PTNQPacer Trendpilot 100 ETF · Technology | Whole market | +9.7% | 14.1% | 0.73 | −28.1% | +305% | 0.07 | 0.65% |
| 71 | Whole market | +6.8% | 17.6% | 0.47 | −39.4% | +198% | 0.46 | 0.03% | |
| 72 | Whole market | +10.4% | 14.1% | 0.78 | −31.7% | +258% | 0.47 | 0.04% | |
| 73 | Whole market | +9.7% | 14.3% | 0.72 | −33.4% | +252% | 0.48 | 0.06% | |
| 74 | Whole market | +2.7% | 2.9% | 0.94 | −6.3% | +32.7% | 0.27 | 0.03% | |
| 75 | FXUFirst Trust Utilities AlphaDEX Fund · Utilities | Whole market | +11.2% | 16.6% | 0.72 | −34.8% | +138% | 0.38 | 0.61% |
| 76 | FLOTiShares Floating Rate Bond ETF · Floating Rate Bonds | Whole market | +4.5% | 1.8% | 2.48 | −13.5% | +35.9% | 0.23 | 0.15% |
| 77 | Whole market | +10.3% | 16.2% | 0.69 | −34.2% | +223% | 0.39 | 0.06% | |
| 78 | Whole market | +11.3% | 18.8% | 0.67 | −38.4% | +170% | 0.24 | — | |
| 79 | Whole market | +6.8% | 19.4% | 0.44 | −38.7% | +122% | 0.18 | 0.09% | |
| 80 | Whole market | +5.2% | 17.5% | 0.38 | −36.4% | +102% | 0.21 | 0.06% | |
| 81 | Whole market | +5.2% | 8.9% | 0.61 | −25.4% | +37.8% | 0.26 | — | |
| 82 | Whole market | +2.9% | 17.9% | 0.25 | −36.9% | +181% | 0.42 | — | |
| 83 | YLDPrincipal Active High Yield ETF · Bonds | Whole market | +4.2% | 6.4% | 0.67 | −28.3% | +62.1% | 0.46 | 0.39% |
| 84 | PJULInnovator U.S. Equity Power Buffer ETF · Broad Market | Whole market | +10.5% | 8.6% | 1.20 | −18.2% | — | 0.42 | 0.79% |
| 85 | Whole market | +8.2% | 16.1% | 0.57 | −39.0% | +211% | 0.51 | 0.20% | |
| 86 | FJANFT Vest U.S. Equity Buffer ETF - January · Multi-Asset | Whole market | +11.1% | 10.5% | 1.05 | −13.6% | — | 0.42 | 0.85% |
| 87 | Whole market | +7.5% | 18.0% | 0.50 | −37.4% | +132% | 0.38 | — | |
| 88 | Whole market | +1.7% | 2.8% | 0.63 | −8.5% | +20.5% | 0.30 | 0.03% | |
| 89 | Whole market | +2.3% | 2.9% | 0.80 | −12.9% | +28.6% | 0.35 | 0.03% | |
| 90 | Whole market | +14.7% | 17.5% | 0.87 | −34.7% | — | 0.35 | 0.26% | |
| 91 | Whole market | +4.4% | 20.9% | 0.31 | −35.8% | +245% | 0.43 | — | |
| 92 | Whole market | +7.5% | 11.0% | 0.71 | −13.7% | — | 0.53 | 0.35% | |
| 93 | Whole market | +4.0% | 20.2% | 0.29 | −29.8% | +93.4% | 0.31 | — | |
| 94 | Same or nearby category | +11.9% | 19.4% | 0.68 | −54.4% | +30.4% | 0.33 | — | |
| 95 | PDBCInvesco Optimum Yield Diversified Commodity Strategy No K-1 ETF · Broad Commodities | Whole market | +11.7% | 19.3% | 0.67 | −40.7% | +153% | 0.18 | 0.74% |
| 96 | SPMOInvesco S&P 500 Momentum ETF · US Momentum Equity | Whole market | +18.7% | 20.8% | 0.93 | −30.9% | +499% | 0.23 | 0.13% |
| 97 | IUSGiShares Core S&P U.S. Growth ETF · US Growth Equity | Whole market | +12.9% | 21.2% | 0.68 | −32.4% | +405% | 0.22 | 0.04% |
| 98 | VNLAJanus Henderson Short Duration Income ETF · Bonds | Whole market | +4.0% | 1.1% | 3.77 | −4.5% | — | 0.36 | 0.25% |
| 99 | DFIVDimensional - International Value ETF · International Equity | Whole market | +14.8% | 16.4% | 0.93 | −25.4% | — | 0.50 | 0.27% |
| 100 | AVLVAvantis U.S. Large Cap Value ETF · US Large-Cap Value | Whole market | +14.0% | 16.9% | 0.86 | −19.5% | — | 0.46 | 0.15% |
MDT against its popular alternatives
The investments people most often weigh against MDT, compared period by period and year by year.
How do MDT's risk and return compare with its alternatives?
This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at MDT, which divides the map into what did better or worse on each measure.
- Only JNJ was both more rewarding and calmer than MDT over the past 5 years, earning a higher annual return with lower volatility.
- Over the past 5 years, MDT returned -1.8% a year, less than the S&P 500's 12.7%, with higher volatility (22.5% against 17.1%).
Green points earned more than MDT with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.
All figures
| Investment | Annual return | Volatility |
|---|---|---|
| CAH Cardinal Health, Inc. | +42.1% | 24.7% |
| MCK McKesson Corporation | +38.7% | 25.0% |
| HCA HCA Healthcare, Inc. | +14.1% | 30.1% |
| JNJ Johnson & Johnson | +12.7% | 17.9% |
| SPY S&P 500State Street SPDR S&P 500 ETF | +12.7% | 17.1% |
| ITGR Integer Holdings Corporation | +6.9% | 35.3% |
| ISRG Intuitive Surgical, Inc. | +5.2% | 34.6% |
| SYK Stryker Corporation | +3.2% | 25.7% |
| BDX Becton, Dickinson and Company | +2.3% | 24.1% |
| UNH UnitedHealth Group Incorporated | +1.1% | 32.1% |
| STE STERIS plc | +0.9% | 26.2% |
| BSX Boston Scientific Corporation | +0.5% | 26.6% |
| GMED Globus Medical, Inc. | +0.3% | 38.6% |
| LIVN LivaNova PLC | −0.4% | 39.6% |
| SNN Smith & Nephew plc | −1.2% | 27.5% |
| ABT Abbott Laboratories | −1.7% | 23.1% |
| MDT This pageMedtronic Plc | −1.8% | 22.5% |
| EW Edwards Lifesciences Corporation | −5.3% | 32.7% |
| ICUI ICU Medical, Inc. | −7.0% | 40.0% |
| ZBH Zimmer Biomet Holdings, Inc. | −7.2% | 27.2% |
| DXCM DexCom, Inc. | −9.2% | 47.3% |
| PODD Insulet Corp. | −13.7% | 44.1% |
| TFX Teleflex Incorporated | −18.2% | 34.5% |
| BAX Baxter International Inc. | −19.8% | 34.9% |
| INSP Inspire Medical Systems, Inc. | −22.3% | 61.0% |
Has MDT consistently beaten its popular alternatives?
This section compares MDT with the investments people most often weigh against it, checking each one over eight periods from one month to ten years. Counting how often an alternative earned more than MDT helps separate lasting outperformance from a single strong stretch.
- Seven of the 23 popular alternatives, led by MCK, ITGR and CAH, outperformed MDT in at least 3 of 5 short-term and 2 of 3 long-term timeframes.
- MCK, ITGR and CAH outperformed MDT in every long-term period and in all but one short-term period, the most consistent record in the group.
- MCK, JNJ and SYK earned more for the risk they took than MDT (a higher Sharpe ratio) and fell less in their worst decline of the past 10 years.
A green cell means the alternative earned more than MDT over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 2 of 3 long-term periods.
| Investment | Periods outperformed | Short term | Long term | Risk · 5 years | Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Volatilitylower is calmer | Sharpehigher is better | Worst declinepast 10 years | Expense | Assets | Overlapsame sectors | ||
| MDT Medtronic Plc (this page) | — | +4.0% | +14.5% | +13.3% | +1.0% | +1.9% | +43.6% | −8.8% | +46.7% | 22.5% | 0.03 | −45.1% | — | $121B | — |
| MCK QualifiedMcKesson Corporation | 5/5 short3/3 longAll-weather | +16.2% | +24.0% | +20.2% | +25.5% | +31.3% | +131% | +413% | +586% | 25.0% | 1.44 | −38.1% | — | $120B | — |
| ITGR QualifiedInteger Holdings Corporation | 4/5 short3/3 longAll-weather | +0.3% | +31.9% | +41.9% | +65.0% | +18.0% | +76.0% | +39.4% | +557% | 35.3% | 0.37 | −56.1% | — | $4.3B | — |
| CAH QualifiedCardinal Health, Inc. | 4/5 short3/3 longAll-weather | +14.3% | +14.3% | +22.5% | +26.1% | +65.3% | +191% | +479% | +349% | 24.7% | 1.55 | −46.1% | — | $60B | — |
| HCA QualifiedHCA Healthcare, Inc. | 3/5 short3/3 long | +9.3% | +26.0% | −2.2% | −0.5% | +8.3% | +97.6% | +93.6% | +513% | 30.1% | 0.59 | −54.7% | — | $101B | — |
| BDX QualifiedBecton, Dickinson and Company | 5/5 short2/3 long | +7.2% | +26.2% | +23.7% | +28.9% | +32.3% | +1.6% | +12.2% | +71.4% | 24.1% | 0.22 | −39.9% | — | $53B | — |
| UNH QualifiedUnitedHealth Group Incorporated | 4/5 short2/3 long | +11.0% | +0.1% | +31.2% | +27.1% | +18.1% | −15.3% | +5.5% | +241% | 32.1% | 0.20 | −61.4% | — | $376B | — |
| LIVN QualifiedLivaNova PLC | 3/5 short2/3 long | +2.0% | +0.6% | +21.1% | +31.4% | +47.3% | +61.3% | −2.2% | +41.4% | 39.6% | 0.18 | −74.2% | — | $4.4B | — |
| ISRG Medical - Instruments & SuppliesIntuitive Surgical, Inc. | 2/5 short3/3 long | +9.0% | +24.0% | −5.9% | −22.1% | −4.5% | +64.1% | +28.9% | +478% | 34.6% | 0.32 | −49.9% | — | $155B | — |
| GMED Medical - DevicesGlobus Medical, Inc. | 2/5 short3/3 long | +6.3% | +3.9% | −18.4% | −9.6% | +28.2% | +53.9% | +1.3% | +243% | 38.6% | 0.20 | −47.9% | — | $11B | — |
| JNJ Drug Manufacturers - GeneralJohnson & Johnson | 2/5 short3/3 long | −3.8% | +4.8% | +13.6% | +27.1% | +36.9% | +84.6% | +82.1% | +196% | 17.9% | 0.76 | −27.4% | — | $625B | — |
| STE Medical - SpecialtiesSTERIS plc | 1/5 short2/3 long | +8.8% | +5.3% | +0.1% | −9.2% | −6.0% | +7.0% | +4.5% | +262% | 26.2% | 0.17 | −36.2% | — | $22B | — |
| SYK Medical - DevicesStryker Corporation | 1/5 short2/3 long | +11.4% | −4.3% | −9.5% | −11.8% | −19.2% | +18.0% | +17.2% | +197% | 25.7% | 0.25 | −43.8% | — | $117B | — |
| ABT Medical - DevicesAbbott Laboratories | 0/5 short2/3 long | +0.3% | +1.6% | +8.4% | −15.3% | −18.7% | +13.0% | −8.0% | +204% | 23.1% | 0.04 | −39.6% | — | $178B | — |
| BSX Medical - DevicesBoston Scientific Corporation | 0/5 short2/3 long | +4.3% | +4.1% | −25.3% | −51.9% | −54.7% | −8.9% | +2.5% | +98.1% | 26.6% | 0.15 | −61.6% | — | $66B | — |
| DXCM Medical - DevicesDexCom, Inc. | 3/5 short1/3 long | −3.8% | +13.3% | +32.7% | +28.9% | +25.3% | −0.3% | −38.4% | +316% | 47.3% | 0.04 | −66.3% | — | $32B | — |
| ICUI Medical - Instruments & SuppliesICU Medical, Inc. | 3/5 short1/3 long | +3.8% | +2.4% | +23.4% | +16.3% | +37.3% | +49.0% | −30.5% | +12.5% | 40.0% | 0.02 | −73.8% | — | $4.0B | — |
| EW Medical - DevicesEdwards Lifesciences Corporation | 2/5 short1/3 long | −0.1% | +3.9% | +8.4% | +3.5% | +17.3% | +27.1% | −23.6% | +125% | 32.7% | 0.01 | −54.3% | — | $51B | — |
| SNN Medical - DevicesSmith & Nephew plc | 1/5 short1/3 long | +7.2% | −2.5% | −13.3% | −8.4% | −17.1% | +41.6% | −5.9% | +20.5% | 27.5% | 0.09 | −55.1% | — | $12B | — |
| PODD Medical - DevicesInsulet Corp. | 0/5 short1/3 long | +1.5% | −14.8% | −29.0% | −49.6% | −56.4% | −1.4% | −52.2% | +255% | 44.1% | -0.12 | −63.0% | — | $9.9B | — |
| BAX Medical - Instruments & SuppliesBaxter International Inc. | 4/5 short0/3 long | +6.9% | +11.1% | +30.2% | +25.9% | +6.2% | −20.7% | −66.7% | −40.7% | 34.9% | -0.45 | −81.2% | — | $13B | — |
| TFX Medical - Instruments & SuppliesTeleflex Incorporated | 2/5 short0/3 long | +5.1% | −1.9% | −0.1% | +8.0% | +1.6% | −28.1% | −63.4% | −17.4% | 34.5% | -0.41 | −76.7% | — | $5.6B | — |
| INSP Medical - DevicesInspire Medical Systems, Inc. | 2/5 short0/3 long | −5.8% | +33.9% | +25.2% | −22.7% | −11.7% | −54.3% | −71.6% | — | 61.0% | -0.10 | −87.7% | — | $2.1B | — |
| ZBH Medical - DevicesZimmer Biomet Holdings, Inc. | 1/5 short0/3 long | +2.1% | +7.3% | +1.1% | +7.5% | −5.6% | −5.5% | −31.1% | −16.1% | 27.2% | -0.14 | −52.1% | — | $18B | — |
How did MDT do year by year?
This table shows each investment's total return in every full calendar year since 1997, along with where MDT ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with MDT and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.
- Among its popular alternatives, HCA came out ahead of MDT most often, in 12 of the 14 years both traded.
- MDT finished ahead of the S&P 500 in 12 of its 29 full calendar years.
- Ranked against its popular alternatives each year, MDT finished in the top quarter in two of 29 years and in the bottom quarter in four. In 2025, it ranked 8 of 24.
Newest year first. Green marks a year in which the fund came out ahead of MDT; gray means the two finished within a fraction of a point. The rank row places MDT among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.
| Investment | Years ahead of MDT | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDT This pageMedtronic Plc | — | +24.0% | +0.3% | +9.6% | −22.6% | −9.8% | +5.7% | +27.3% | +15.2% | +15.3% | −5.4% | +8.6% | +28.1% | +42.8% | +10.6% | +5.8% | −13.8% | +42.6% | −36.3% | −5.2% | −6.3% | +16.8% | +2.7% | +7.3% | −10.3% | −14.8% | +66.4% | −1.5% | +42.1% | +55.3% |
| Rank among alternatives | Top quarter in 2 of 29 | 8 of 24 | 12 of 24 | 9 of 24 | 17 of 24 | 21 of 24 | 17 of 24 | 13 of 24 | 9 of 23 | 19 of 23 | 14 of 23 | 11 of 22 | 11 of 22 | 10 of 22 | 15 of 21 | 10 of 20 | 18 of 20 | 8 of 20 | 11 of 20 | 13 of 19 | 15 of 19 | 7 of 18 | 13 of 18 | 14 of 18 | 13 of 18 | 16 of 16 | 4 of 13 | 5 of 12 | 6 of 12 | 3 of 12 |
| SPY S&P 500State Street SPDR S&P 500 ETF | 16 of 29 | +17.7% | +24.9% | +26.2% | −18.2% | +28.7% | +18.3% | +31.2% | −4.6% | +21.7% | +12.0% | +1.2% | +13.5% | +32.3% | +16.0% | +1.9% | +15.1% | +26.4% | −36.8% | +5.1% | +15.9% | +4.8% | +10.7% | +28.2% | −21.6% | −11.7% | −9.8% | +20.4% | +28.7% | +33.5% |
| MCK McKesson Corporation | 19 of 29 | +44.5% | +23.7% | +24.1% | +51.8% | +44.2% | +27.1% | +26.7% | −28.4% | +12.0% | −28.3% | −4.5% | +29.3% | +67.7% | +25.6% | +11.8% | +13.8% | +62.9% | −40.4% | +29.7% | −1.2% | +64.9% | −1.4% | +19.9% | −27.2% | +4.9% | +61.2% | −71.3% | +46.9% | +96.3% |
| ITGR Integer Holdings Corporation | 12 of 25 | −40.8% | +33.8% | +44.7% | −20.0% | +5.4% | +0.9% | +5.5% | +68.3% | +53.8% | −43.9% | +6.5% | +11.4% | +90.4% | +5.2% | −8.5% | +25.6% | −27.3% | +32.4% | −25.7% | +3.5% | +16.0% | −47.0% | +44.8% | −19.1% | +27.8% | — | — | — | — |
| CAH Cardinal Health, Inc. | 15 of 29 | +76.3% | +19.0% | +34.1% | +54.1% | −0.4% | +10.1% | +18.0% | −24.5% | −12.7% | −17.5% | +12.6% | +23.0% | +66.0% | +3.8% | +8.1% | +21.4% | −4.4% | −39.6% | −9.8% | −5.8% | +18.7% | −4.7% | +3.5% | −8.3% | −2.5% | +108% | −36.8% | +51.7% | +29.1% |
| HCA HCA Healthcare, Inc. | 12 of 14 | +56.7% | +11.8% | +13.8% | −5.6% | +57.6% | +11.6% | +20.2% | +43.4% | +18.7% | +9.4% | −7.8% | +53.8% | +58.1% | +70.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BDX Becton, Dickinson and Company | 13 of 24 | −12.5% | −5.3% | −2.7% | +5.1% | +1.9% | −6.8% | +22.2% | +6.6% | +31.2% | +9.2% | +12.6% | +28.3% | +44.3% | +7.3% | −9.7% | +9.4% | +17.6% | −16.9% | +20.7% | +18.3% | +7.2% | +39.8% | +35.6% | −6.4% | — | — | — | — | — |
| UNH UnitedHealth Group Incorporated | 17 of 29 | −33.1% | −2.4% | +0.8% | +6.9% | +45.2% | +21.3% | +20.0% | +14.5% | +39.8% | +38.4% | +18.3% | +36.5% | +41.0% | +8.6% | +42.2% | +19.9% | +14.8% | −54.3% | +8.3% | −13.5% | +41.2% | +51.4% | +39.4% | +18.1% | +15.3% | +131% | +23.5% | −13.4% | +10.3% |
| LIVN LivaNova PLC | 3 of 10 | +32.9% | −10.5% | −6.8% | −36.5% | +32.0% | −12.2% | −17.5% | +14.4% | +77.7% | −24.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ISRG Intuitive Surgical, Inc. | 15 of 25 | +8.5% | +54.7% | +27.1% | −26.2% | +31.8% | +38.4% | +23.4% | +31.2% | +72.7% | +16.1% | +3.3% | +37.7% | −21.7% | +5.9% | +79.6% | −15.0% | +139% | −60.7% | +237% | −18.2% | +193% | +134% | +38.7% | −38.6% | +18.0% | — | — | — | — |
| GMED Globus Medical, Inc. | 8 of 13 | +5.6% | +55.2% | −28.2% | +2.9% | +10.7% | +10.8% | +36.0% | +5.3% | +65.7% | −10.8% | +17.0% | +17.8% | +92.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JNJ Johnson & Johnson | 15 of 29 | +47.5% | −4.8% | −8.6% | +6.0% | +11.4% | +10.8% | +16.2% | −5.1% | +24.4% | +15.3% | +1.2% | +17.3% | +34.6% | +10.8% | +9.9% | −0.6% | +11.3% | −7.7% | +3.6% | +12.4% | −3.4% | +25.2% | −2.0% | −7.9% | +14.0% | +14.2% | +12.5% | +29.0% | +34.3% |
| STE STERIS plc | 16 of 29 | +24.6% | −5.6% | +20.2% | −23.4% | +29.5% | +25.5% | +44.1% | +23.6% | +31.7% | −9.1% | +17.9% | +37.2% | +40.9% | +19.2% | −16.5% | +32.5% | +26.3% | −16.4% | +15.4% | +1.4% | +6.0% | +4.9% | −6.8% | +32.8% | +13.2% | +57.4% | −63.9% | +17.8% | +10.9% |
| SYK Stryker Corporation | 18 of 29 | −1.5% | +21.3% | +23.8% | −7.4% | +10.2% | +18.2% | +35.3% | +2.4% | +30.8% | +30.7% | 0.0% | +27.4% | +39.3% | +12.1% | −6.1% | +7.9% | +26.7% | −46.0% | +36.2% | +24.5% | −7.7% | +13.7% | +26.8% | +15.2% | +15.6% | +45.6% | +26.6% | +47.9% | +25.0% |
| ABT Abbott Laboratories | 16 of 29 | +12.9% | +4.8% | +2.3% | −20.7% | +30.5% | +28.1% | +22.1% | +29.1% | +52.0% | −12.3% | +1.9% | +20.1% | +24.3% | +20.3% | +21.8% | −8.3% | +4.6% | −2.5% | +18.1% | +26.9% | −13.5% | +9.2% | +19.3% | −26.8% | +17.0% | +35.8% | −24.7% | +51.9% | +31.4% |
| BSX Boston Scientific Corporation | 12 of 29 | +6.8% | +54.5% | +24.9% | +8.9% | +18.2% | −20.5% | +28.0% | +42.6% | +14.6% | +17.3% | +39.2% | +10.2% | +110% | +7.3% | −29.5% | −15.9% | +16.3% | −33.5% | −32.3% | −29.8% | −31.1% | −3.3% | +72.9% | +76.3% | +76.3% | −37.5% | −18.4% | +16.9% | −23.5% |
| DXCM DexCom, Inc. | 11 of 20 | −14.7% | −37.3% | +9.6% | −15.6% | +45.2% | +69.0% | +82.6% | +109% | −3.9% | −27.1% | +48.8% | +55.5% | +160% | +45.9% | −31.7% | +68.8% | +193% | −68.8% | −10.5% | −33.8% | — | — | — | — | — | — | — | — | — |
| ICUI ICU Medical, Inc. | 17 of 29 | −8.1% | +55.6% | −36.7% | −33.7% | +10.7% | +14.6% | −18.5% | +6.3% | +46.6% | +30.6% | +37.7% | +28.5% | +4.6% | +35.4% | +23.3% | +0.2% | +10.0% | −8.0% | −11.5% | +3.8% | +43.4% | −20.3% | −8.1% | +25.7% | +47.8% | +97.5% | −30.7% | +77.8% | +57.1% |
| EW Edwards Lifesciences Corporation | 18 of 25 | +15.2% | −2.9% | +2.2% | −42.4% | +42.0% | +17.3% | +52.3% | +35.9% | +20.3% | +18.6% | +24.0% | +93.7% | −27.1% | +27.6% | −12.6% | +86.1% | +58.1% | +19.6% | −2.3% | +13.0% | +0.9% | +37.0% | +18.4% | −7.8% | +55.4% | — | — | — | — |
| SNN Smith & Nephew plc | 14 of 26 | +36.8% | −7.3% | +4.4% | −20.2% | −16.2% | −10.4% | +30.8% | +8.9% | +18.5% | −13.9% | −1.4% | +31.8% | +32.5% | +17.5% | −6.9% | +4.1% | +61.7% | −43.2% | +10.7% | +14.1% | −9.4% | +24.6% | +38.3% | +2.4% | +33.7% | +40.4% | — | — | — |
| PODD Insulet Corp. | 12 of 18 | +8.9% | +20.3% | −26.3% | +10.6% | +4.1% | +49.3% | +116% | +15.0% | +83.1% | −0.3% | −17.9% | +24.1% | +74.8% | +12.7% | +21.5% | +8.5% | +85.0% | −67.1% | — | — | — | — | — | — | — | — | — | — | — |
| BAX Baxter International Inc. | 13 of 29 | −33.3% | −22.4% | −21.9% | −39.6% | +8.5% | −3.0% | +28.4% | +2.9% | +47.3% | +17.6% | −2.1% | +8.4% | +7.3% | +38.5% | +0.1% | −11.6% | +11.7% | −6.3% | +26.8% | +24.8% | +10.7% | +15.2% | +11.2% | −46.8% | +22.8% | +56.1% | −0.5% | +30.3% | +26.0% |
| TFX Teleflex Incorporated | 16 of 29 | −30.7% | −28.2% | +0.5% | −23.6% | −19.9% | +9.8% | +46.3% | +4.5% | +55.4% | +23.7% | +15.7% | +23.9% | +33.8% | +18.9% | +16.6% | +2.3% | +10.7% | −18.6% | −0.7% | +1.1% | +27.1% | +9.5% | +14.8% | −8.1% | +8.6% | +43.6% | −30.6% | +22.2% | +46.8% |
| INSP Inspire Medical Systems, Inc. | 4 of 7 | −50.2% | −8.9% | −19.2% | +9.5% | +22.3% | +153% | +75.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ZBH Zimmer Biomet Holdings, Inc. | 11 of 24 | −14.0% | −12.5% | −3.8% | +4.3% | −17.0% | +3.8% | +45.4% | −13.3% | +17.9% | +1.5% | −8.8% | +22.8% | +41.2% | +26.2% | −0.5% | −9.2% | +46.3% | −38.9% | −15.6% | +16.2% | −15.8% | +13.8% | +69.6% | +35.9% | — | — | — | — | — |
Risk and diversification
How MDT has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.
What were MDT's worst declines?
A drawdown is the decline from a peak to the lowest point before a new high. This section presents MDT's five deepest drawdowns since it began trading in 1986, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.
- In all four of MDT's worst declines, the S&P 500 held up better over the same dates.
- The slowest recovery came after MDT fell 57.6% from January 2006 to March 2009; it did not regain that peak until May 2013, four years later.
Green means MDT fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.
| During | MDT fell | S&P 500, same dates | Peak | Low | Time to the low | Back at the peak | Time to recover |
|---|---|---|---|---|---|---|---|
| 2008 financial crisis | −57.6% | −43.6% | Jan 2006 | Mar 2009 | 3.2 years | May 2013 | 4.2 years |
| No named crash | −48.3% | — | Nov 1992 | Apr 1993 | 5 months | Sep 1994 | 17 months |
| 2022 bear market | −45.1% | −5.8% | Sep 2021 | Oct 2023 | 2.1 years | Not yet | — |
| Dot-com bust | −44.2% | −38.9% | Dec 2000 | Jul 2002 | 19 months | Jan 2006 | 3.5 years |
| Covid crash | −39.9% | −32.9% | Feb 2020 | Mar 2020 | 1 month | Jan 2021 | 10 months |
How did MDT do in stock market crashes?
This section measures how far MDT, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.
- Among its popular alternatives, JNJ held up best, falling less than MDT in eight of the ten crashes they both traded through.
- MDT fell further than the S&P 500 in five of the ten crashes it has traded through. The clearest case was the 2015 China and oil sell-off, when MDT fell 17.6% and the S&P 500 fell 12.8%.
Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than MDT.
| Investment | Held up better | 2023 regional bank crisisMar 2023 | 2022 bear marketJan 2022 | Covid crashFeb 2020 | Late-2018 sell-offSep 2018 | February 2018 volatility shockFeb 2018 | 2015 China and oil sell-offAug 2015 | 2011 euro debt crisisJul 2011 | 2010 flash crashMay 2010 | 2008 financial crisisOct 2007 | Dot-com bustMar 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MDT This pageMedtronic Plc | — | −2.1% | −27.9% | −36.0% | −13.8% | −7.2% | −17.6% | −18.0% | −1.5% | −56.5% | −44.2% |
| SPY S&P 500State Street SPDR S&P 500 ETF | 5 of 10 | −3.4% | −24.5% | −33.7% | −19.3% | −6.5% | −12.8% | −17.9% | −1.5% | −55.2% | −47.5% |
| MCK McKesson Corporation | 6 of 10 | −0.9% | −10.5% | −32.1% | −20.7% | −6.5% | −30.8% | −14.2% | −3.5% | −57.7% | −39.4% |
| ITGR Integer Holdings Corporation | 2 of 9 | −5.1% | −41.5% | −52.3% | −21.0% | −12.3% | −46.0% | −29.4% | 0.0% | −41.1% | — |
| CAH Cardinal Health, Inc. | 5 of 10 | −3.5% | −21.0% | −32.1% | −25.5% | −4.6% | −15.9% | −17.5% | −1.8% | −57.9% | −36.1% |
| HCA HCA Healthcare, Inc. | 1 of 7 | −2.2% | −39.5% | −54.4% | −20.6% | −3.8% | −31.3% | −49.0% | — | — | — |
| BDX Becton, Dickinson and Company | 4 of 9 | −2.0% | −19.7% | −21.8% | −20.4% | −10.8% | −15.1% | −18.3% | −1.6% | −34.1% | — |
| UNH UnitedHealth Group Incorporated | 5 of 10 | −1.8% | −16.9% | −35.9% | −18.6% | −6.7% | −12.4% | −20.7% | −0.8% | −72.4% | −19.8% |
| LIVN LivaNova PLC | 1 of 5 | −6.3% | −49.0% | −55.3% | −32.9% | −5.0% | — | — | — | — | — |
| ISRG Intuitive Surgical, Inc. | 1 of 9 | −2.7% | −47.6% | −40.5% | −24.3% | −8.4% | −14.7% | −20.6% | −3.8% | −75.9% | — |
| GMED Globus Medical, Inc. | 1 of 6 | −5.9% | −34.8% | −38.0% | −28.0% | −5.1% | −23.6% | — | — | — | — |
| JNJ Johnson & Johnson | 8 of 10 | −1.1% | −12.7% | −25.4% | −16.9% | −8.2% | −9.0% | −9.8% | −0.1% | −34.4% | −35.9% |
| STE STERIS plc | 2 of 10 | −2.8% | −36.2% | −35.8% | −17.3% | −7.1% | −19.6% | −23.9% | −2.8% | −49.6% | −35.9% |
| SYK Stryker Corporation | 3 of 10 | −1.4% | −31.4% | −43.8% | −18.8% | −8.8% | −15.6% | −23.0% | −3.8% | −58.6% | −26.9% |
| ABT Abbott Laboratories | 5 of 10 | −2.5% | −27.9% | −29.7% | −11.7% | −8.8% | −27.4% | −11.5% | −0.5% | −22.3% | −45.7% |
| BSX Boston Scientific Corporation | 3 of 10 | −1.2% | −25.2% | −40.0% | −18.7% | −8.0% | −15.2% | −24.0% | −3.2% | −63.5% | −56.7% |
| DXCM DexCom, Inc. | 1 of 9 | −4.4% | −48.8% | −36.8% | −27.8% | −5.1% | −47.6% | −33.2% | −6.1% | −87.0% | — |
| ICUI ICU Medical, Inc. | 5 of 10 | −1.9% | −43.5% | −26.0% | −24.6% | −6.1% | −29.8% | −16.3% | −4.0% | −43.9% | −38.6% |
| EW Edwards Lifesciences Corporation | 4 of 9 | −3.8% | −36.0% | −33.2% | −20.0% | −6.1% | −9.7% | −19.4% | −2.4% | −31.9% | — |
| SNN Smith & Nephew plc | 5 of 10 | −0.4% | −38.8% | −46.2% | −12.7% | −4.8% | −18.6% | −21.8% | −3.9% | −55.2% | −26.7% |
| PODD Insulet Corp. | 2 of 9 | −2.0% | −33.2% | −39.9% | −31.1% | −4.1% | −37.2% | −36.5% | 0.0% | −89.6% | — |
| BAX Baxter International Inc. | 2 of 10 | −3.6% | −39.1% | −23.0% | −20.9% | −8.7% | −23.0% | −18.6% | −1.9% | −31.6% | −55.7% |
| TFX Teleflex Incorporated | 4 of 10 | −2.6% | −47.2% | −42.9% | −16.7% | −8.5% | −10.8% | −21.6% | −0.5% | −42.8% | −29.5% |
| INSP Inspire Medical Systems, Inc. | 0 of 4 | −9.6% | −44.7% | −53.7% | −29.5% | — | — | — | — | — | — |
| ZBH Zimmer Biomet Holdings, Inc. | 3 of 9 | 0.0% | −23.9% | −49.6% | −26.0% | −8.2% | −14.8% | −20.3% | −2.1% | −62.0% | — |
How closely does MDT move with the S&P 500?
Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares MDT with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 10 years.
- 16 of the 22 popular alternatives had a higher capture ratio (upside capture divided by downside capture) than MDT's 0.59, led by MCK, CAH and JNJ.
- MCK took just 27% of the S&P 500's losses, against 105% for MDT, while still keeping 72% of its gains.
- Over the past 10 years, MDT captured 62% of the S&P 500's gains in rising months and 105% of its losses in falling months, with a beta of 0.68. Its share of the market's losses was larger than its share of the gains.
Monthly total returns over the past 10 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than MDT's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.
| Investment | Upside capture | Downside capture | Capture ratio | Beta |
|---|---|---|---|---|
| MDT This pageMedtronic Plc | 62% | 105% | 0.59 | 0.68 |
| MCK McKesson Corporation | 72% | 27% | 2.71 | 0.56 |
| CAH Cardinal Health, Inc. | 71% | 51% | 1.40 | 0.75 |
| JNJ Johnson & Johnson | 64% | 53% | 1.20 | 0.46 |
| ITGR Integer Holdings Corporation | 118% | 111% | 1.06 | 1.00 |
| DXCM DexCom, Inc. | 97% | 97% | 1.00 | 1.13 |
| PODD Insulet Corp. | 81% | 82% | 1.00 | 0.92 |
| UNH UnitedHealth Group Incorporated | 81% | 82% | 0.98 | 0.70 |
| HCA HCA Healthcare, Inc. | 135% | 140% | 0.97 | 1.37 |
| ABT Abbott Laboratories | 76% | 79% | 0.96 | 0.64 |
| STE STERIS plc | 89% | 97% | 0.92 | 0.76 |
| ISRG Intuitive Surgical, Inc. | 136% | 154% | 0.88 | 1.28 |
| SYK Stryker Corporation | 82% | 96% | 0.86 | 0.88 |
| GMED Globus Medical, Inc. | 118% | 148% | 0.80 | 1.03 |
| EW Edwards Lifesciences Corporation | 88% | 120% | 0.73 | 0.97 |
| BSX Boston Scientific Corporation | 76% | 109% | 0.70 | 0.72 |
| BDX Becton, Dickinson and Company | 53% | 77% | 0.69 | 0.48 |
| LIVN LivaNova PLC | 74% | 129% | 0.57 | 0.89 |
| ICUI ICU Medical, Inc. | 78% | 136% | 0.57 | 0.69 |
| SNN Smith & Nephew plc | 50% | 98% | 0.52 | 0.63 |
| TFX Teleflex Incorporated | 79% | 170% | 0.47 | 1.01 |
| ZBH Zimmer Biomet Holdings, Inc. | 62% | 139% | 0.44 | 0.88 |
| BAX Baxter International Inc. | 45% | 125% | 0.36 | 0.64 |
What diversifies MDT?
Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with MDT's. Because such investments tend not to fall at the same time, pairing MDT with them can reduce a portfolio's overall swings.
- Moving a fifth of the money in MDT into DXJ would have cut the portfolio's volatility by 17% over the past 5 years and raised its annual return (-4.2% for MDT alone, +1.9% for the mix).
- Among large ETFs, LVHI, DXJ and EMLP have moved largely independently of MDT over the past 5 years, with correlations of 0.48 or lower, and each still earned a positive 5-year return.
- FIX made money in seven of the ten calendar years in which MDT lost money.
Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 5 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The year columns are the years in which MDT lost money. The last two columns show a portfolio that is 80% MDT and 20% the other investment, rebalanced monthly.
ETFs
| Investment | Correlation | 5Y return | Sharpe | 2022 | 2021 | 2016 | 2010 | 2008 | 2007 | 2006 | 2002 | 2001 | 1999 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDT Medtronic Plc (this page) | 1.00 | −8.8% | 0.03 | −22.6% | −9.8% | −5.4% | −13.8% | −36.3% | −5.2% | −6.3% | −10.3% | −14.8% | −1.5% | 23.7% | −4.2% |
| LVHI InternationalFranklin International Low Volatility High Dividend Index ETF | 0.48 | +119% | 1.48 | +3.8% | +17.8% | — | — | — | — | — | — | — | — | 19.9% | +0.1% |
| DXJ InternationalWisdomTree Japan Hedged Equity Fund | 0.24 | +225% | 1.34 | +6.0% | +18.0% | +1.1% | −1.8% | −20.8% | −7.4% | — | — | — | — | 19.7% | +1.9% |
| EMLP Broad MarketFirst Trust North American Energy Infrastructure Fund | 0.47 | +101% | 1.04 | +10.4% | +23.1% | +29.8% | — | — | — | — | — | — | — | 20.4% | −0.2% |
| SMH TechnologyVanEck Semiconductor ETF | 0.01 | +323% | 0.97 | −33.5% | +42.1% | +35.6% | +19.0% | −44.7% | +6.0% | −6.7% | −47.0% | −14.6% | — | 20.2% | +4.5% |
| DBEF InternationalXtrackers MSCI EAFE Hedged Equity ETF | 0.43 | +85.0% | 0.96 | −5.1% | +19.6% | +6.3% | — | — | — | — | — | — | — | 20.0% | −0.5% |
| GLD CommoditiesSPDR Gold Shares | 0.23 | +126% | 0.96 | −0.8% | −4.2% | +8.0% | +29.3% | +4.9% | +30.4% | +22.6% | — | — | — | 20.0% | +0.5% |
| SPMO Broad MarketInvesco S&P 500 Momentum ETF | 0.23 | +136% | 0.93 | −10.4% | +22.7% | +7.4% | — | — | — | — | — | — | — | 20.3% | +1.1% |
| XLE EnergyState Street Energy Select Sector SPDR ETF | 0.37 | +177% | 0.93 | +64.4% | +53.3% | +28.0% | +21.9% | −39.0% | +36.8% | +18.0% | −14.8% | −18.2% | +18.1% | 21.4% | +1.4% |
Stocks
| Investment | Correlation | 5Y return | Sharpe | 2022 | 2021 | 2016 | 2010 | 2008 | 2007 | 2006 | 2002 | 2001 | 1999 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDT Medtronic Plc (this page) | 1.00 | −8.8% | 0.03 | −22.6% | −9.8% | −5.4% | −13.8% | −36.3% | −5.2% | −6.3% | −10.3% | −14.8% | −1.5% | 23.7% | −4.2% |
| CAH Medical - DistributionCardinal Health, Inc. | 0.41 | +479% | 1.55 | +54.1% | −0.4% | −17.5% | +21.4% | −39.6% | −9.8% | −5.8% | −8.3% | −2.5% | −36.8% | 21.6% | +3.7% |
| CLS Hardware, Equipment & PartsCelestica Inc. | 0.09 | +3,143% | 1.47 | +1.3% | +37.9% | +7.4% | +2.8% | −20.5% | −25.7% | −26.0% | −65.1% | −25.6% | +350% | 23.1% | +15.5% |
| FIX Engineering & ConstructionComfort Systems USA, Inc. | 0.05 | +1,636% | 1.46 | +17.0% | +89.0% | +18.3% | +8.7% | −15.2% | +2.1% | +38.9% | −9.4% | +73.7% | −58.7% | 21.3% | +11.9% |
| MCK Medical - DistributionMcKesson Corporation | 0.21 | +413% | 1.44 | +51.8% | +44.2% | −28.3% | +13.8% | −40.4% | +29.7% | −1.2% | −27.2% | +4.9% | −71.3% | 20.6% | +3.4% |
| MPC Oil & Gas Refining & MarketingMarathon Petroleum Corporation | 0.25 | +690% | 1.41 | +86.6% | +61.0% | +0.7% | — | — | — | — | — | — | — | 21.5% | +5.7% |
Common questions
What was MDT's worst drawdown?
MDT's deepest decline since it began trading in 1986 was 57.6%, from January 2006 to March 2009. It took about four years from the low to climb back to its old high.
What were MDT's best and worst years?
Over 29 full calendar years, MDT's best year was 2000, when it returned 66.4%. Its worst was 2008, with a return of -36.3%.
Is there a better investment than MDT?
Among MDT's popular alternatives, JNJ earned more than MDT with less volatility over the past 5 years: 12.7% a year at 17.9% volatility, against a loss of 1.8% a year at 22.5%. Looking beyond its popular alternatives, TAK (pharmaceuticals) and NVS (pharmaceuticals) earned more than MDT with less volatility over the past 5 years. TAK returned 11.9% a year at 19.4% volatility, against a loss of 1.8% a year at 22.5%.
Is MDT more volatile than the S&P 500?
Yes. MDT's volatility over the past 5 years was 22.5%, 1.3 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, MDT's return lands within 22.5% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.
What is MDT's Sharpe ratio?
MDT's Sharpe ratio over the past 5 years was 0.03, against 0.79 for the S&P 500, so MDT earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.
How correlated is MDT with the S&P 500?
Over the past 5 years, MDT's monthly returns had a correlation of 0.36 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against MDT instead: the lower it is, the more that option would diversify a MDT holding.
What are the best alternatives to MDT?
Of the 23 popular alternatives we compared, seven outperformed MDT in at least 3 of 5 short-term and 2 of 3 long-term timeframes, with dividends reinvested: MCK, ITGR and CAH.
Did MDT outperform the S&P 500?
MDT finished ahead of the S&P 500 (SPY) in 12 of 29 full calendar years. In 2025, it returned +24.0%, against +17.7% for the index.
How did MDT do in stock market crashes?
MDT fell less than the S&P 500 (SPY) in three of the ten major crashes it has traded through, and further in five. The clearest case was the 2015 China and oil sell-off, when MDT fell 17.6% and the S&P 500 fell 12.8%.
What diversifies MDT?
These had a low correlation with MDT over the past 5 years and still earned a positive 5-year return: among large ETFs, LVHI (correlation 0.48), DXJ (correlation 0.24) and EMLP (correlation 0.47); among large stocks, CAH (correlation 0.41), CLS (correlation 0.09) and FIX (correlation 0.05). A correlation near zero means the two have moved largely independently.
How we measure
- Short-term periods are 1M, 3M, 6M, YTD, 1Y; long-term periods are 3Y, 5Y, 10Y. An investment outperformed in a period when its total return, with dividends reinvested, was higher than MDT's. Returns within 0.5 points or 3% of MDT's, whichever is larger, count as a tie.
- "Qualified" means outperforming in at least 3 of 5 short-term periods and 2 of 3 long-term periods. "All-weather" means outperforming in every long-term period and all but one short-term period.
- Popular alternatives are the funds and stocks most often compared with this one. We include only those that trade today, are not leveraged or inverse, and hold at least $200 million.
- Volatility is the annualized standard deviation of daily returns over 5 years, a measure of how much the price typically swings in a year. The Sharpe ratio is the return above cash for each unit of that volatility.
- A decline, or drawdown, runs from a peak to the lowest close before the next high. The worst decline ever uses all the price history we have; comparisons between funds use the past 10 years so that younger funds are judged on the same stretch.
- Sector overlap is the share of assets two funds hold in the same sectors. Correlation and the mixed-portfolio figures use monthly returns.
- Upside and downside capture follow Morningstar's definition: the compound monthly return in the months the S&P 500 rose (or fell), divided by the S&P 500's compound return in those months. Beta measures how strongly monthly returns have moved with the S&P 500. All three use the same window for every investment.
- Figures are computed from daily adjusted prices and update after each trading day. Past performance does not predict future results.
More research
Popular alternatives to MDT
MCKMcKesson
CAHCardinal Health
HCAHCA Healthcare
BDXBecton, Dickinson and Company
UNHUnitedHealth Group
ISRGIntuitive Surgical
JNJJohnson & Johnson
SYKStryker
ABTAbbott Laboratories
BSXBoston Scientific
EWEdwards Lifesciences